Indefinite Delivery Contract SPE2DX16D9390
- Not listed
- The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DX program, has an ultimate completion date of November 30, 2024 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
- The federal contract IDV award SPE2DX16D9957 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the woman-owned small business DMS Pharmaceutical Group Inc. by the Defense Logistics Agency (DLA) under the SPE2DX program. The contract covers the delivery of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter...
- The federal contract IDV award SPE2DR25D9114 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 with an ultimate completion date of December 31, 2036. It was awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items,...
- The federal contract IDV award SPE2DX18D9391 is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999.00 contract, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract covers...
- The federal contract IDV award, SPE2DX20D9546, is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00 and issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valid through December 31, 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC covers an...
- The federal contract IDV award SPE2DX17D9536 is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and held by DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The IDC was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide. The contract covers a...
- The federal contract IDV award SPE2DX15D9145 is a single-award Indefinite Delivery Contract (IDC) granted by the Defense Logistics Agency (DLA) to the prime contractor, DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
- The federal contract IDV award SPE2DX15D9787 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract's ultimate completion date is December 31, 2025, and it enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DX15D9344 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities...
The federal contract IDV award SPE2DX16D9390 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valid through November 2023, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers a diverse portfolio of pharmaceutical items across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain. The contract is not associated with any set-aside designations, allowing the woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/3/16 |